Proposing a nasal trehalose‐induced autophagy approach against SARS‐CoV 2

Proposing a nasal trehalose‐induced autophagy approach against SARS‐CoV 2

Bibliographic Details
Main Authors:	Mojde Pajokh, Mohammad Pourfridoni
Format:	Article
Language:	English
Published:	Wiley 2021-09-01
Series:	Health Science Reports
Online Access:	https://doi.org/10.1002/hsr2.375

Similar Items

A Study of 3CLpros as Promising Targets against SARS-CoV and SARS-CoV-2
by: Seri Jo, et al.
Published: (2021-04-01)

Flavonoids against the SARS-CoV-2 induced inflammatory storm
by: Alena Liskova, et al.
Published: (2021-06-01)

Correlates of Vaccine-Induced Protection against SARS-CoV-2
by: Till Koch, et al.
Published: (2021-03-01)

Autophagy and SARS-CoV-2 infection: A possible smart targeting of the autophagy pathway
by: Shahla Shojaei, et al.
Published: (2020-01-01)

Reducing transmission of SARS-CoV-2 in ophthalmology with nasal and oral decontamination
by: Jesse S. Pelletier, et al.
Published: (2020-08-01)

Impact of repeated nasal sampling on detection and quantification of SARS-CoV-2
by: Joshua M. Levy, et al.
Published: (2021-07-01)

Diabetes and coronavirus infections (SARS-CoV, MERS-CoV, and SARS-CoV-2)
by: Azadeh Haghi Navand, et al.
Published: (2020-01-01)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
by: Jung Eun Huh, et al.
Published: (2021-04-01)

Comparison between SARS-CoV and SARS-CoV 2
by: Fang Meng
Published: (2021-01-01)

Unlocking COVID therapeutic targets: A structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike
by: João Trigueiro-Louro, et al.
Published: (2020-01-01)

SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
by: T.M. Abdelghany, et al.
Published: (2021-03-01)

Music of microbiota against SARS CoV-2
by: Goran Belojevic, et al.
Published: (2019-01-01)

Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia
by: Andrés Pizzorno, et al.
Published: (2020-07-01)

The emerging SARS-CoV, MERS-CoV, and SARS-CoV-2: An insight into the viruses zoonotic aspects
by: Karima A. Al-Salihi, et al.
Published: (2021-01-01)

Computational analysis of SARS-CoV-2, SARS-CoV, and MERS-CoV genome using MEGA
by: Vipan Kumar Sohpal
Published: (2020-09-01)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
by: Yun-yu Zhang, et al.
Published: (2020-08-01)

Cytokine-Induced Modulation of SARS-CoV2 Receptor Expression in Primary Human Nasal Epithelial Cells
by: Mahnaz Ramezanpour, et al.
Published: (2021-07-01)

Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2
by: Yetian Dong, et al.
Published: (2020-10-01)

Differential Tropism of SARS-CoV and SARS-CoV-2 in Bat Cells
by: Susanna K.P. Lau, et al.
Published: (2020-12-01)

Electrostatic features for nucleocapsid proteins of SARS-CoV and SARS-CoV-2
by: Wenhan Guo, et al.
Published: (2021-04-01)

Structure and Function of Major SARS-CoV-2 and SARS-CoV Proteins
by: Ritesh Gorkhali, et al.
Published: (2021-06-01)

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses
by: Zeinab Abdelrahman, et al.
Published: (2020-09-01)

Autopsy Tool in Unknown Diseases: The Experience with Coronaviruses (SARS-CoV, MERS-CoV, SARS-CoV-2)
by: Francesco Sessa, et al.
Published: (2021-03-01)

SARS-CoV-2 promote autophagy to suppress type I interferon response
by: Xianfeng Hui, et al.
Published: (2021-05-01)

Modulation of Autophagy by SARS-CoV-2: A Potential Threat for Cardiovascular System
by: Puneet Kaur Randhawa, et al.
Published: (2020-11-01)

Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19
by: Carmen Elena Gómez, et al.
Published: (2021-03-01)

Proposed therapies and vaccine developing for COVID-19 (SARS CoV-2)
by: Gamal, Abdelaziz, et al.
Published: (2020-06-01)

Molecular Structure of SARS-CoV-2 Virus and the Proposed Related Drugs
by: Ali Hojabr Rajeooni, et al.
Published: (2020-11-01)

Vaccine against SARS-CoV-2: Challenges and considerations
by: Ruchi Chaube
Published: (2021-03-01)

Antiviral Effect of Budesonide against SARS-CoV-2
by: Natalie Heinen, et al.
Published: (2021-07-01)

Viral Related Tools against SARS-CoV-2
by: Laura Fernandez-Garcia, et al.
Published: (2020-10-01)

Drug Weaponry to Fight Against SARS-CoV-2
by: Elena Cabezón, et al.
Published: (2020-08-01)

Thymoquinone: shield and sword against SARS-CoV-2
by: Andrei P. Sommer, et al.

Construction of Recombinant Adenovirus Vaccine against SARS-CoV
by: Wen-Chieh Yang, et al.
Published: (2004)

Phytochemicals against SARS-CoV as potential drug leads
by: Shasank Sekhar Swain, et al.
Published: (2021-03-01)

Main Pharmacological Strategies Against SARS-CoV-2
by: Thais Gonçalves Fontes, et al.
Published: (2020-09-01)

Prospects of Neutralizing Nanobodies Against SARS-CoV-2
by: Fangfang Chen, et al.
Published: (2021-05-01)

Epigallocatechin-3-gallate (EGCG): a potential molecule for the development of therapeutics against emerging SARS-CoV-1, MERS-CoV and SARS-CoV-2 coronaviruses
by: Jeswin Joseph, et al.
Published: (2021-09-01)

Fluoroquinolone Antibiotics Exhibit Low Antiviral Activity against SARS-CoV-2 and MERS-CoV
by: Stacey L. P. Scroggs, et al.
Published: (2021-12-01)

Effect of Environmental Conditions on SARS-CoV-2 Stability in Human Nasal Mucus and Sputum
by: M. Jeremiah Matson, et al.
Published: (2020-09-01)

Cannot write session to /tmp/vufind_sessions/sess_guca0bbiomqjcf20pik8m5q6fi